findmyKOL
Clinical trialNCT00290823CompletedPhase 3Interventional

Corticosteroids to Reduce Frequency of Seizures in Neurocysticercosis Patients

SponsorNational Institute of Allergy and Infectious Diseases (NIAID)Enrollment110Neurocysticercosis
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Hector H. Garcia, MD, PhD

    Department of Microbiology, Universidad Peruana Cayetano Heredia

    Study Director
  • Theodore E. Nash, MD

    Gastrointestinal Parasites Section, Laboratory of Parasitic Diseases, NIAID

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Peru
  • Instituto Especializado En Ciencias Neurologicas

    Lima, Peru

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Apr 2006
Primary completion
31 Mar 2011
Completion
31 Mar 2011
Last update posted
3 Feb 2017
Registered enrollment
110
Registry id
NCT00290823

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.